Jumlah Saham Beredar | 1,613,911 shares |
Saham Orang Dalam | 16,667,513 shares |
Orang Dalam Sejati | 61 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
3801 out of 11323Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
3785 out of 11244Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan MedAvail Holdings, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
ABG Management Ltd.
10% Owner -
|
2,920,780 | 117,898 | |
WTT-MedAvail Ltd ABG
10% Owner -
|
5,894,897 | 117,898 | |
ABG-WTT Global Life Science Capital Partners GP Ltd
10% Owner -
|
2,920,780 | 117,898 | |
ABG-WTT Global Life Science Capital Partners GP, L.P.
10% Owner -
|
2,920,780 | 117,898 | |
Buzz Aldrin Director - [D] | 100,000 | 100,000 | |
Ally Bridge Group (NY) LLC
10% Owner -
|
1,487,058 | 117,898 | |
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.
10% Owner -
|
2,920,780 | 117,898 | |
Ally Bridge MedAlpha Management GP, LLC
10% Owner -
|
2,920,780 | 58,416 | |
Ally Bridge MedAlpha Management L.P.
10% Owner -
|
2,920,780 | 58,416 | |
Ally Bridge MedAlpha Master Fund L.P.
10% Owner -
|
2,920,780 | 117,898 | |
Alyeska Investment Group, L.P.
10% Owner -
|
7,539,411 | 150,788 | |
Aronne Louis J. Director - [D] | 80,705 | 80,705 | |
Ashton Robert C. Jr. | 10,000 | ||
Helen Ciesielski | 0 | ||
Carl DeFreitas Interim CFO - [O] | 1,000 | 1,000 | |
Christopher C Dewey Director - [D] | 328,982 | 328,982 | |
Janine DiVenuto
10% Owner -
|
7,757,000 | 7,757,000 | |
Peter Diamandis Director - [D] | 5,444 | 5,444 | |
Mark Edward Doerr Chief Executive Officer, Director - [D] [O] | 188,701 | 3,774 | |
Joseph DosSantos Interim President and CFO - [O] | 5,000 | 5,000 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Einhorn Andrew J. | 0 | ||
Faulkner Robert C. | 0 | ||
Ryan Ferguson | 249,319 | ||
Fleischer Glen R. - | 0 | 0 | |
Gerald Gradwell | 215,815 | ||
Jeremy Green
Director, 10% Owner -
[D]
|
7,058,821 | 381,956 | |
Robert J Hariri Director - [D] | 119,364 | 119,364 | |
Steven Hess | 131,000 | ||
Paul D Johnson | 86,372 | ||
Edwin Kilroy | 876,723 | ||
Michael R Kramer | 14,165 | ||
Jack Levine Director - [D] | 27,000 | 27,000 | |
Zhengguang Lyu Director - [D] | 122,228 | 122,228 | |
Peter Levy COO; Executive VP - [O] | 750,000 | 750,000 | |
Victor E Mandel Director - [D] | 120,377 | 120,377 | |
David J Matlin
10% Owner -
|
1,267,477 | 1,267,477 | |
Laurie Mcgraw | 86,372 | ||
Fraser Mackay | 113,175 | ||
Joseph Mannello Chief Executive Officer, Director - [D] [O] | 1,567,557 | 1,567,557 | |
Will Misloski | 0 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
John Nosta Director - [D] | 32,274 | 32,274 | |
Anand Parekh
10% Owner -
|
7,539,411 | 150,788 | |
Christopher Pechock Director - [D] | 385,257 | 385,257 | |
Andrew Joel Ponte Director - [D] | 97,499 | 97,499 | |
Neil Prezioso | 0 | ||
Ren Ren
Director, 10% Owner -
[D]
|
18,182 | 18,182 | |
Agriculture Science & Technology Co, Ltd RENS
10% Owner -
|
3,000,000 | 3,000,000 | |
RENS Technology Inc
10% Owner -
|
3,000,000 | 3,000,000 | |
Dave Rawlins | 298,950 | ||
RedCo II Master Fund, L.P.
Director, 10% Owner -
[D]
|
11,458,679 | 381,956 | |
Redmile Group, LLC
Director, 10% Owner -
[D]
|
19,097,796 | 381,956 | |
Ramona Seabaugh Chief Financial Officer - [O] | 1,222 | 1,222 | |
Sapna Srivastava Director - [D] | 200,000 | 200,000 | |
Stettin Glen D. | 14,165 | ||
Kenrick Bryce Toussaint Chief Executive Officer - [O] | 10,000 | 10,000 | |
John Craig Venter | 3,000 | ||
Fan Yu
10% Owner -
|
2,920,780 | 117,898 | |
Guiying Zhao | 0 | ||
Eric Zaltas Director - [D] | 16,529 | 16,529 | |
Bin Zhou | 0 | ||
Hamel Platerink Gerard van | 0 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di MDVLQ / MedAvail Holdings, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di MDVLQ / MedAvail Holdings, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-10-02 | 2023-09-28 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 5.6971 | -303 | -2 | 1,222 | ||||
2023-10-02 | 2023-09-01 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 680 | 1,525 | ||||||
2023-03-23 | 2023-03-21 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 0.3070 | -3,287 | -1 | 18,319 | ||||
2023-03-07 | 2023-03-03 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 0.3366 | -6,727 | -2 | 21,606 | ||||
2023-03-07 | 2023-03-06 | 4 | Doerr Mark Edward | MDVL | Common Stock | D | 0.3112 | -72,785 | -23 | 188,701 | ||||
2023-03-07 | 2023-03-03 | 4 | Doerr Mark Edward | MDVL | Common Stock | D | 0.3262 | -20,773 | -7 | 261,486 | ||||
2023-03-03 | 2023-03-01 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 20,000 | 28,333 | ||||||
2023-03-03 | 2023-03-01 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 8,333 | 8,333 | ||||||
2023-03-03 | 2023-03-01 | 4 | Doerr Mark Edward | MDVL | Common Stock | D | 282,259 | 282,259 | ||||||
2022-07-06 | 2022-07-01 | 4 | Redmile Group, LLC | MDVL | Common Stock | D | 1.0625 | 7,639,117 | 8,117 | 19,097,796 | ||||
2022-07-06 | 2022-07-01 | 4 | Redmile Group, LLC | MDVL | Common Stock | I | 1.0625 | 9,411,765 | 10,000 | 34,604,516 | ||||
2022-05-23 | 3 | PAREKH ANAND | MDVL | Common Stock | D | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND | MDVL | Common Stock | D | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND Footnotes | MDVL | Common Stock | I | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND Footnotes | MDVL | Common Stock | I | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND Footnotes | MDVL | Common Stock | I | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND Footnotes | MDVL | Common Stock | I | 7,539,411 | ||||||||
2022-04-12 | 2022-04-08 | 4 | Hess Steven | MDVL | Stock Option (Right to Buy) | D | 1.96 | 131,000 | 131,000 | |||||
2022-04-12 | 2022-04-08 | 4 | Hess Steven | MDVL | Restricted Stock Units | D | 131,000 | 131,000 | ||||||
2022-04-06 | 3 | RedCo II Master Fund, L.P. | MDVL | Common Stock | D | 11,458,679 | ||||||||
2022-04-06 | 2022-04-04 | 4 | Redmile Group, LLC | MDVL | Warrants to Purchase Shares of Common Stock | I | 1.25 | 7,058,821 | 7,058,821 | |||||
2022-04-06 | 2022-04-04 | 4 | Redmile Group, LLC | MDVL | Common Stock | I | 1.0625 | 14,117,646 | 15,000 | 25,192,751 | ||||
2022-04-06 | 2022-04-04 | 4 | ABG WTT-MedAvail Ltd | MDVL | Warrant (Right to Buy) | I | 1.25 | 1.0625 | 1,487,058 | 1,580 | 1,487,058 | |||
2022-04-06 | 2022-04-04 | 4 | ABG WTT-MedAvail Ltd | MDVL | Warrant (Right to Buy) | I | 1.25 | 1.0625 | 5,571,764 | 5,920 | 5,571,764 | |||
2022-04-06 | 2022-04-04 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 1.0625 | 2,974,117 | 3,160 | 5,894,897 | ||||
2022-04-06 | 2022-04-04 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 1.0625 | 11,143,529 | 11,840 | 15,029,480 | ||||
2022-03-18 | 2022-03-16 | 4 | Seabaugh Ramona | MDVL | Stock Option (Right to Buy) | D | 0.83 | 60,000 | 60,000 | |||||
2022-03-18 | 2022-03-16 | 4 | Seabaugh Ramona | MDVL | Restricted Stock Units | D | 60,000 | 60,000 | ||||||
2022-03-18 | 2022-03-16 | 4 | Johnson Paul D | MDVL | Common Stock | D | 0.83 | 86,372 | 86,372 | |||||
2022-03-18 | 2022-03-16 | 4 | MCGRAW LAURIE | MDVL | Common Stock | D | 0.83 | 86,372 | 86,372 | |||||
2022-02-14 | 2022-02-09 | 4 | Seabaugh Ramona | MDVL | Restricted Stock Units | D | 25,000 | 25,000 | ||||||
2022-02-14 | 2022-02-09 | 4 | Seabaugh Ramona | MDVL | Stock Option (Right to Buy) | D | 1.38 | 25,000 | 25,000 | |||||
2022-01-12 | 2022-01-10 | 4 | Doerr Mark Edward | MDVL | Restricted Stock Units | D | 846,775 | 846,775 | ||||||
2022-01-12 | 2022-01-10 | 4 | Doerr Mark Edward | MDVL | Stock Option (Right to Buy) | D | 1.24 | 1,173,127 | 1,173,127 | |||||
2021-07-02 | 2021-06-30 | 4 | Kramer Michael R | MDVL | Stock Option (Right to Buy) | D | 12.25 | 18,438 | 18,438 | |||||
2021-07-02 | 2021-06-30 | 4 | Stettin Glen D. | MDVL | Stock Option (Right to Buy) | D | 12.25 | 18,438 | 18,438 | |||||
2021-07-02 | 2021-06-30 | 4 | Gradwell Gerald | MDVL | Stock Option (Right to Buy) | D | 12.25 | 18,438 | 18,438 | |||||
2021-03-25 | 2021-03-22 | 4 | Prezioso Neil | MDVL | Restricted Stock Units | D | 3,465 | 201,963 | ||||||
2021-03-25 | 2021-03-22 | 4 | Prezioso Neil | MDVL | Stock Option (Right to Buy) | D | 15.15 | 18,794 | 198,498 | |||||
2021-03-25 | 2021-03-22 | 4 | Misloski Will | MDVL | Restricted Stock Units | D | 2,145 | 202,405 | ||||||
2021-03-25 | 2021-03-22 | 4 | Misloski Will | MDVL | Stock Option (Right to Buy) | D | 15.15 | 11,634 | 200,260 | |||||
2021-03-25 | 2021-03-22 | 4 | Ferguson Ryan | MDVL | Restricted Stock Units | D | 2,821 | 267,444 | ||||||
2021-03-25 | 2021-03-22 | 4 | Ferguson Ryan | MDVL | Stock Option (Right to Buy) | D | 15.15 | 15,304 | 264,623 | |||||
2021-03-25 | 2021-03-22 | 4 | Kilroy Edwin | MDVL | Restricted Stock Units | D | 5,897 | 914,604 | ||||||
2021-03-25 | 2021-03-22 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 15.15 | 31,984 | 908,707 | |||||
2021-01-08 | 2021-01-06 | 4 | Kramer Michael R | MDVL | Common Stock | D | 13.27 | 14,165 | 14,165 | |||||
2021-01-08 | 2021-01-06 | 4 | Stettin Glen D. | MDVL | Common Stock | D | 13.27 | 14,165 | 14,165 | |||||
2021-01-08 | 2021-01-06 | 4 | Gradwell Gerald | MDVL | Stock Option (Right to Buy) | D | 13.27 | 14,165 | 215,815 | |||||
2021-01-05 | 2020-12-31 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.9959 | 5,727 | 86 | 2,920,780 | ||||
2021-01-05 | 2020-12-31 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.9959 | 6,943 | 104 | 3,885,951 | ||||
2020-12-30 | 2020-12-29 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.0000 | 45 | 1 | 2,915,053 | ||||
2020-12-30 | 2020-12-29 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.0000 | 55 | 1 | 3,879,008 | ||||
2020-12-30 | 2020-12-28 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9766 | 3,213 | 45 | 2,915,008 | ||||
2020-12-30 | 2020-12-28 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9766 | 3,894 | 54 | 3,878,953 | ||||
2020-12-28 | 2020-12-24 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9919 | 4,019 | 56 | 2,911,795 | ||||
2020-12-28 | 2020-12-24 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9919 | 4,871 | 68 | 3,875,059 | ||||
2020-12-28 | 2020-12-23 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9865 | 9,810 | 137 | 2,907,776 | ||||
2020-12-28 | 2020-12-23 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9865 | 11,890 | 166 | 3,870,188 | ||||
2020-12-28 | 2020-12-22 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.7016 | 7,661 | 105 | 2,897,966 | ||||
2020-12-28 | 2020-12-22 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.7016 | 9,287 | 127 | 3,858,298 | ||||
2020-12-22 | 2020-12-21 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.3147 | 7,358 | 98 | 2,890,305 | ||||
2020-12-22 | 2020-12-21 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.3147 | 8,919 | 119 | 3,849,011 | ||||
2020-12-22 | 2020-12-18 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.5946 | 8,408 | 114 | 2,882,947 | ||||
2020-12-22 | 2020-12-18 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.5946 | 10,192 | 139 | 3,840,092 | ||||
2020-12-18 | 2020-12-17 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.0000 | 1,029 | 14 | 2,874,539 | ||||
2020-12-18 | 2020-12-17 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.0000 | 1,248 | 17 | 3,829,900 | ||||
2020-12-18 | 2020-12-17 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.1201 | 5,731 | 75 | 2,873,510 | ||||
2020-12-18 | 2020-12-17 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.1201 | 6,946 | 91 | 3,828,652 | ||||
2020-12-18 | 2020-12-16 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.0611 | 12,851 | 168 | 2,867,779 | ||||
2020-12-18 | 2020-12-16 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.0611 | 15,578 | 203 | 3,821,706 | ||||
2020-12-16 | 2020-12-15 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.0821 | 9,027 | 118 | 2,854,928 | ||||
2020-12-16 | 2020-12-15 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.0821 | 10,942 | 143 | 3,806,128 | ||||
2020-12-16 | 2020-12-15 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 12.4955 | 4,276 | 53 | 2,845,901 | ||||
2020-12-16 | 2020-12-15 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 12.4955 | 5,184 | 65 | 3,795,186 | ||||
2020-12-16 | 2020-12-14 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 12.2443 | 6,535 | 80 | 2,841,625 | ||||
2020-12-16 | 2020-12-14 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 12.2443 | 7,922 | 97 | 3,790,002 | ||||
2020-11-30 | 3 | Ally Bridge Group (NY) LLC See footnotes | MDVL | Common Stock | I | 3,782,080 | ||||||||
2020-11-30 | 3 | Ally Bridge Group (NY) LLC See footnotes | MDVL | Common Stock | I | 2,835,090 | ||||||||
2020-11-27 | 3 | Green Jeremy | MDVL | Common Stock | I | 11,724,726 | ||||||||
2020-11-18 | 2020-11-17 | 4 | Rawlins Dave | MDVL | Stock Option (Right to Buy) | D | 1.71 | 74,320 | 298,950 | |||||
2020-11-18 | 2020-11-17 | 4 | Rawlins Dave | MDVL | Stock Option (Right to Buy) | D | 1.71 | 224,630 | 224,630 | |||||
2020-11-18 | 2020-11-17 | 4 | Mackay Fraser | MDVL | Stock Option (Right to Buy) | D | 2.09 | 48,559 | 113,175 | |||||
2020-11-18 | 2020-11-17 | 4 | Mackay Fraser | MDVL | Stock Option (Right to Buy) | D | 2.09 | 16,876 | 64,616 | |||||
2020-11-18 | 2020-11-17 | 4 | Mackay Fraser | MDVL | Stock Option (Right to Buy) | D | 2.09 | 47,740 | 47,740 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 1.71 | 42,325 | 876,723 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 5,136 | 834,398 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 92,160 | 829,262 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 108,388 | 737,102 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 127,171 | 628,714 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 81,715 | 501,543 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 350,811 | 419,828 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 28,512 | 69,017 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 40,505 | 40,505 | |||||
2020-11-18 | 2020-11-17 | 4 | Gradwell Gerald Dowth International Limited | MDVL | Warrant (Right to Buy) | I | 1.57 | 201,650 | 201,650 | |||||
2020-11-18 | 2020-11-17 | 4 | Misloski Will | MDVL | Stock Option (Right to Buy) | D | 2.09 | 188,626 | 188,626 | |||||
2020-11-18 | 2020-11-17 | 4 | Prezioso Neil | MDVL | Stock Option (Right to Buy) | D | 1.71 | 179,704 | 179,704 | |||||
2020-11-18 | 2020-11-17 | 4 | Ferguson Ryan | MDVL | Stock Option (Right to Buy) | D | 1.71 | 249,319 | 249,319 | |||||
2020-10-02 | 2020-10-01 | 4 | Mannello Joseph | MYOS | Common Stock | D | 180,000 | 1,567,557 | ||||||
2020-04-06 | 2020-03-31 | 4 | Dewey Christopher C | MYOS | Common Stock | D | 6,611 | 328,982 | ||||||
2020-04-06 | 2020-03-31 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 45,455 | 385,257 | ||||||
2020-04-06 | 2020-03-31 | 4 | Mannello Joseph | MYOS | Common Stock | D | 16,529 | 1,387,557 | ||||||
2020-04-06 | 2020-03-31 | 4 | MANDEL VICTOR E | MYOS | Common Stock | D | 41,322 | 120,377 | ||||||
2020-04-06 | 2020-03-31 | 4 | Hariri Robert J | MYOS | Common Stock | D | 3,306 | 119,364 | ||||||
2020-04-06 | 2020-03-31 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 29,752 | 80,705 | ||||||
2020-04-06 | 2020-03-31 | 4 | Zaltas Eric | MYOS | Common Stock | D | 16,529 | 16,529 | ||||||
2020-04-06 | 2020-03-31 | 4 | Ponte Andrew Joel | MYOS | Common Stock | D | 3,306 | 97,499 | ||||||
2020-03-10 | 2020-03-06 | 4 | MATLIN DAVID J | MYOS | Common Stock | D | 1.2100 | 206,611 | 250 | 1,267,477 | ||||
2020-03-09 | 2020-03-05 | 4 | Ponte Andrew Joel | MYOS | Common Stock | D | 1.2100 | 82,645 | 100 | 94,193 | ||||
2020-03-09 | 2020-03-05 | 4 | Dewey Christopher C | MYOS | Common Stock | D | 1.2100 | 82,645 | 100 | 322,371 | ||||
2020-03-09 | 2020-03-05 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 1.2100 | 82,645 | 100 | 339,802 | ||||
2020-03-09 | 2020-03-05 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.2100 | 681,818 | 825 | 1,371,028 | ||||
2020-02-12 | 3 | Ponte Andrew Joel | MYOS | Common Stock | D | 23,096 | ||||||||
2020-02-12 | 3 | Ponte Andrew Joel | MYOS | Common Stock | D | 23,096 | ||||||||
2020-02-12 | 3 | Ponte Andrew Joel | MYOS | Common Stock | D | 23,096 | ||||||||
2019-08-19 | 3 | Dewey Christopher C | MYOS | Common Stock | D | 479,452 | ||||||||
2019-08-19 | 3 | Dewey Christopher C | MYOS | Common Stock | D | 479,452 | ||||||||
2019-08-19 | 3 | Dewey Christopher C | MYOS | Common Stock | D | 479,452 | ||||||||
2019-03-27 | 2019-03-27 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.4600 | 171,233 | 250 | 689,210 | ||||
2019-03-27 | 2019-03-27 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 1.4600 | 34,247 | 50 | 257,157 | ||||
2019-03-27 | 3 | MATLIN DAVID J | MYOS | Common Stock | D | 2,121,732 | ||||||||
2019-03-27 | 3 | MATLIN DAVID J | MYOS | Common Stock | D | 2,121,732 | ||||||||
2019-03-27 | 3 | MATLIN DAVID J | MYOS | Common Stock | D | 2,121,732 | ||||||||
2019-02-08 | 2019-02-06 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 19,562 | 50,953 | ||||||
2019-02-08 | 2019-02-06 | 4 | MANDEL VICTOR E | MYOS | Common Stock | D | 29,930 | 79,055 | ||||||
2019-02-08 | 2019-02-06 | 4 | Mannello Joseph | MYOS | Common Stock | D | 14,085 | 517,977 | ||||||
2019-02-08 | 2019-02-06 | 4 | Nosta John | MYOS | Common Stock | D | 23,083 | 32,274 | ||||||
2019-02-08 | 2019-02-06 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 29,930 | 222,910 | ||||||
2019-02-08 | 2019-02-06 | 4 | Hariri Robert J | MYOS | Common Stock | D | 10,955 | 116,058 | ||||||
2018-04-27 | 2018-04-25 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.2400 | 221,774 | 275 | 503,892 | ||||
2018-04-27 | 2018-04-25 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 1.2400 | 80,645 | 100 | 192,980 | ||||
2018-01-05 | 2018-01-03 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 11,949 | 112,335 | ||||||
2018-01-05 | 2018-01-03 | 4 | Hariri Robert J | MYOS | Common Stock | D | 7,353 | 105,103 | ||||||
2018-01-05 | 2018-01-03 | 4 | MANDEL VICTOR E | MYOS | Common Stock | D | 10,110 | 49,125 | ||||||
2018-01-05 | 2018-01-03 | 4 | Mannello Joseph | MYOS | Common Stock | D | 7,353 | 282,118 | ||||||
2018-01-05 | 2018-01-03 | 4 | Nosta John | MYOS | Common Stock | D | 9,191 | 9,191 | ||||||
2018-01-05 | 2018-01-03 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 9,191 | 31,391 | ||||||
2017-12-26 | 2017-12-21 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.4600 | 20,336 | 30 | 274,765 | ||||
2017-12-08 | 2017-12-08 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3500 | 5,500 | 7 | 254,429 | ||||
2017-12-08 | 2017-12-07 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3600 | 15,800 | 21 | 249,429 | ||||
2017-12-08 | 2017-12-06 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3500 | 16,819 | 23 | 233,629 | ||||
2017-11-16 | 2017-11-16 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3500 | 12,150 | 16 | 216,810 | ||||
2017-11-16 | 2017-11-15 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3100 | 1,100 | 1 | 204,660 | ||||
2017-11-16 | 2017-11-14 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.2700 | 11,750 | 15 | 203,560 | ||||
2017-08-28 | 2017-08-24 | 4 | Mannello Joseph | MYOS | Stock Option | D | 4.00 | 300,000 | 300,000 | |||||
2016-12-30 | 2016-12-28 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 4,386 | 100,386 | ||||||
2016-12-30 | 2016-12-28 | 4 | Hariri Robert J | MYOS | Common Stock | D | 4,386 | 97,750 | ||||||
2016-12-30 | 2016-12-28 | 4 | MANDEL VICTOR E | MYOS | Common Stock | D | 1,755 | 39,015 | ||||||
2016-12-30 | 2016-12-28 | 4 | Mannello Joseph | MYOS | Common Stock | D | 2,631 | 191,810 | ||||||
2016-12-30 | 2016-11-15 | 4 | Mannello Joseph | MYOS | Common Stock | D | 10,000 | 189,179 | ||||||
2016-12-30 | 2016-12-28 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 4,386 | 122,228 | ||||||
2016-12-09 | 2016-12-02 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.5300 | 931 | 1 | 117,842 | ||||
2016-12-09 | 2016-12-01 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.5500 | 3,600 | 6 | 116,911 | ||||
2016-12-09 | 2016-12-01 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.4500 | 11,323 | 16 | 113,311 | ||||
2016-12-09 | 2016-11-30 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.4300 | 18,483 | 26 | 101,988 | ||||
2016-09-26 | 2016-09-23 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.6999 | 50,000 | 85 | 83,505 | ||||
2016-09-07 | 2016-09-06 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.5980 | 22,905 | 37 | 33,505 | ||||
2016-09-07 | 2016-09-01 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.6000 | 600 | 1 | 10,600 | ||||
2016-06-21 | 2016-06-17 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.6500 | 10,000 | 16 | 10,000 | ||||
2016-04-13 | 2016-04-11 | 4 | REN REN | MYOS | Common Stock | D | 18,182 | 18,182 | ||||||
2016-04-08 | 2016-04-08 | 4 | Mannello Joseph | MYOS | Common Stock | D | 2.0500 | 900 | 2 | 179,179 | ||||
2016-04-08 | 2016-04-07 | 4 | Mannello Joseph | MYOS | Common Stock | D | 2.0500 | 400 | 1 | 178,279 | ||||
2016-04-08 | 2016-04-06 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.9200 | 3,117 | 6 | 177,879 | ||||
2016-04-06 | 3 | Mannello Joseph | MYOS | Common Stock | D | 337,268 | ||||||||
2016-04-06 | 3 | Mannello Joseph | MYOS | Common Stock | D | 337,268 | ||||||||
2016-04-06 | 2016-04-05 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.7550 | 3,800 | 7 | 174,762 | ||||
2016-04-06 | 2016-04-04 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.7400 | 2,328 | 4 | 170,962 | ||||
2016-03-14 | 3 | RENS Agriculture Science & Technology Co, Ltd | MYOS | Common Stock | I | 3,000,000 | ||||||||
2016-03-14 | 3 | RENS Agriculture Science & Technology Co, Ltd | MYOS | Common Stock | I | 3,000,000 | ||||||||
2016-03-14 | 3 | RENS Agriculture Science & Technology Co, Ltd | MYOS | Common Stock | I | 3,000,000 | ||||||||
2016-03-14 | 3 | RENS Agriculture Science & Technology Co, Ltd | MYOS | Common Stock | I | 3,000,000 | ||||||||
2016-01-15 | 3 | LEVINE JACK | MYOS | Common Stock | D | 27,000 | ||||||||
2016-01-15 | 3 | LEVINE JACK | MYOS | Common Stock | D | 27,000 | ||||||||
2016-01-15 | 3 | MANDEL VICTOR E | MYOS | Common Stock | D | 74,520 | ||||||||
2016-01-15 | 3 | MANDEL VICTOR E | MYOS | Common Stock | D | 74,520 | ||||||||
2015-12-29 | 2015-12-24 | 4 | Toussaint Kenrick Bryce | MYOS | Common Stock | D | 10,000 | 10,000 | ||||||
2015-12-21 | 2015-12-17 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.7300 | 1,000 | 3 | 93,364 | ||||
2015-11-09 | 2015-11-06 | 4 | DosSantos Joseph | MYOS | Common Stock | D | 5,000 | 5,000 | ||||||
2015-09-30 | 2015-09-29 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.7000 | 1,500 | 4 | 92,364 | ||||
2015-09-30 | 2015-09-28 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.6500 | 800 | 2 | 90,864 | ||||
2015-09-25 | 2015-09-25 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.6900 | 1,400 | 4 | 90,064 | ||||
2015-09-25 | 2015-09-24 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.4800 | 4,500 | 11 | 88,664 | ||||
2015-09-25 | 2015-09-23 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.3600 | 6,250 | 15 | 84,164 | ||||
2015-09-11 | 2015-09-11 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.6500 | 1,000 | 2 | 77,914 | ||||
2015-09-11 | 2015-09-09 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7500 | 3,000 | 5 | 76,914 | ||||
2015-09-08 | 2015-09-04 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 1.7600 | 5,000 | 9 | 22,200 | ||||
2015-09-08 | 2015-09-08 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7200 | 5,000 | 9 | 73,914 | ||||
2015-09-08 | 2015-09-04 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7500 | 7,500 | 13 | 68,914 | ||||
2015-09-08 | 2015-09-03 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7200 | 5,500 | 9 | 61,414 | ||||
2015-09-08 | 2015-09-01 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7300 | 2,250 | 4 | 55,914 | ||||
2015-09-08 | 2015-08-31 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.6300 | 5,000 | 8 | 53,664 | ||||
2015-09-01 | 2015-08-28 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7400 | 2,750 | 5 | 48,664 | ||||
2015-07-27 | 2015-07-23 | 4 | Hariri Robert J | MYOS | Common Stock | D | 3.2000 | 9,000 | 29 | 45,914 | ||||
2015-04-07 | 2015-03-30 | 4 | Hariri Robert J | MYOS | Common Stock | D | 4.7500 | 2,000 | 10 | 36,914 | ||||
2015-01-12 | 2015-01-12 | 4 | Aldrin Buzz | MYOS | Stock Option | D | 12.50 | 3,000 | 3,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Venter John Craig | MYOS | Stock Option | D | 12.50 | 3,000 | 3,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 12.50 | 4,000 | 4,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Levy Peter | MYOS | Stock Option | D | 12.50 | 10,000 | 10,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Hariri Robert J | MYOS | Stock Option | D | 12.50 | 25,000 | 25,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Hariri Robert J | MYOS | Stock Option | D | 12.50 | 3,000 | 3,000 | |||||
2015-01-12 | 2015-01-12 | 4 | PECHOCK CHRISTOPHER | MYOS | Stock Option | D | 12.50 | 6,000 | 6,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Diamandis Peter | MYOS | Stock Option | D | 12.50 | 4,000 | 4,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Aronne Louis J. | MYOS | Stock Option | D | 12.50 | 6,000 | 6,000 | |||||
2015-01-12 | 2015-01-12 | 4 | DosSantos Joseph | MYOS | Stock Option | D | 12.50 | 10,000 | 10,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Ashton Robert C. Jr. | MYOS | Stock Option | D | 12.50 | 10,000 | 10,000 | |||||
2014-12-29 | 2014-12-12 | 4 | Hariri Robert J | MYOS | Common Stock | D | 7.8400 | 1,000 | 8 | 34,914 | ||||
2014-12-04 | 2014-12-04 | 4 | Hariri Robert J | MYOS | Common Stock | D | 7.9200 | 200 | 2 | 33,914 | ||||
2014-12-04 | 2014-12-02 | 4 | Hariri Robert J | MYOS | Common Stock | D | 8.1880 | 2,000 | 16 | 33,714 | ||||
2014-08-18 | 2014-08-18 | 4 | Diamandis Peter | MYOS | Common Stock | D | 14.5100 | 3,444 | 50 | 5,444 | ||||
2014-07-14 | 2014-07-09 | 4 | Venter John Craig | MYOS | Stock Option | D | 13.00 | 14,600 | 14,600 | |||||
2014-05-20 | 2014-05-19 | 4 | DosSantos Joseph | MYOS | Stock Option | D | 12.55 | 20,000 | 20,000 | |||||
2014-05-09 | 2014-05-07 | 4 | Hariri Robert J | MYOS | Stock Option | D | 12.10 | 30,000 | 30,000 | |||||
2014-03-12 | 2014-03-10 | 4 | Hariri Robert J | MYOS | Stock Option | D | 8.60 | 2,500 | 2,500 | |||||
2014-03-12 | 2014-03-10 | 4 | Aronne Louis J. | MYOS | Stock Option | D | 8.60 | 7,500 | 7,500 | |||||
2014-03-12 | 2014-03-10 | 4 | Diamandis Peter | MYOS | Stock Option | D | 8.60 | 2,500 | 2,500 | |||||
2014-03-12 | 2014-03-10 | 4 | Levy Peter | MYOS | Stock Option | D | 8.60 | 4,000 | 4,000 | |||||
2014-03-12 | 2014-03-10 | 4 | Aldrin Buzz | MYOS | Stock Option | D | 8.60 | 2,500 | 2,500 | |||||
2014-03-12 | 2014-03-10 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 8.60 | 2,500 | 2,500 | |||||
2014-03-05 | 2014-03-03 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 2,000 | 17,200 | ||||||
2014-02-24 | 3 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 196,000 | ||||||||
2014-02-24 | 3 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 196,000 | ||||||||
2014-02-24 | 3 | PECHOCK CHRISTOPHER | MYOS | Common Stock | I | 104,000 | ||||||||
2014-02-24 | 3 | PECHOCK CHRISTOPHER | MYOS | Common Stock | I | 104,000 | ||||||||
2014-02-19 | 2014-02-18 | 4 | DeFreitas Carl | MYOS | Stock Option | D | 12.50 | 8,000 | 8,000 | |||||
2014-02-04 | 2014-02-03 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.15 | 150,000 | 150,000 | |||||
2013-12-02 | 2013-11-27 | 4 | DeFreitas Carl | MYOS | Stock Option | D | 0.25 | 100,000 | 100,000 | |||||
2013-12-02 | 2013-08-21 | 4 | DeFreitas Carl | MYOS | Stock Option | D | 0.25 | 50,000 | 50,000 | |||||
2013-10-10 | 2013-10-08 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.12 | 150,000 | 150,000 | |||||
2013-07-24 | 2013-07-01 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.19 | 150,000 | 150,000 | |||||
2013-07-24 | 2013-04-01 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.14 | 150,000 | 150,000 | |||||
2013-05-17 | 2013-04-25 | 4 | Fleischer Glen R. | MYOS | Common Stock | D | -5,000,000 | 0 | ||||||
2013-03-04 | 2013-02-28 | 4 | DeFreitas Carl | MYOS | Stock Option | D | 0.25 | 100,000 | 100,000 | |||||
2013-02-19 | 3 | DeFreitas Carl | MYOS | Common Stock | D | 1,000 | ||||||||
2013-02-15 | 2013-02-07 | 4 | Hariri Robert J | MYOS | Stock Option | D | 0.35 | 5,000,000 | 5,000,000 | |||||
2013-02-15 | 3 | Srivastava Sapna | MYOS | Common Stock | D | 100,000 | ||||||||
2013-02-15 | 2013-02-08 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.20 | 250,000 | 250,000 | |||||
2013-02-15 | 2013-02-08 | 4 | Srivastava Sapna | MYOS | Common Stock | D | 100,000 | 200,000 | ||||||
2013-01-09 | 2013-01-07 | 4 | Hariri Robert J | MYOS | Stock Option | D | 0.25 | 250,000 | 250,000 | |||||
2013-01-09 | 2013-01-07 | 4 | Aronne Louis J. | MYOS | Stock Option | D | 0.25 | 250,000 | 250,000 | |||||
2013-01-09 | 2013-01-07 | 4 | Diamandis Peter | MYOS | Stock Option | D | 0.25 | 250,000 | 250,000 | |||||
2013-01-09 | 2013-01-07 | 4 | Levy Peter | MYOS | Stock Option | D | 0.25 | 1,000,000 | 1,000,000 | |||||
2013-01-09 | 2012-11-20 | 4 | Levy Peter | MYOS | Stock Option | D | 0.20 | 2,000 | 2,000 | |||||
2013-01-09 | 2013-01-07 | 4 | Aldrin Buzz | MYOS | Stock Option | D | 0.25 | 250,000 | 250,000 | |||||
2013-01-08 | 2013-01-02 | 4 | Fleischer Glen R. | MYOS | Common Stock | D | 5,000,000 | 5,000,000 | ||||||
2012-12-03 | 2012-07-06 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 0.2500 | 160,000 | 40 | 760,000 | ||||
2012-07-02 | 2012-06-29 | 4 | Hariri Robert J | MYOS | 18% Convertible Promissory Note | D | 0.20 | 0 | ||||||
2012-07-02 | 2012-06-29 | 4 | Hariri Robert J | MYOS | Common Stock | D | 0.2000 | 507,306 | 101 | 9,885,681 | ||||
2012-07-02 | 2012-06-29 | 4 | Hariri Robert J | MYOS | Common Stock | D | 0.2000 | 828,375 | 166 | 9,378,375 | ||||
2012-05-31 | 2012-05-24 | 4 | Aldrin Buzz | MYOS | Stock Option | D | 0.14 | 250,000 | 250,000 | |||||
2012-05-31 | 2012-05-24 | 4 | Aldrin Buzz | MYOS | Common Stock | D | 100,000 | 100,000 | ||||||
2012-05-08 | 2012-05-07 | 4 | Levy Peter | ATTH | Common Stock | D | 250,000 | 750,000 | ||||||
2012-02-14 | 2012-02-10 | 4 | Levy Peter | ATTH | Common Stock | D | 500,000 | 500,000 | ||||||
2012-02-09 | 2011-10-14 | 5 | DiVenuto Janine | ATTH | Common Stock | D | 0.2400 | 1,000 | 0 | 7,757,000 | ||||
2012-02-09 | 2011-10-11 | 5 | DiVenuto Janine | ATTH | Common Stock | D | 0.2000 | 1,000 | 0 | 7,756,000 |